Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cathet Cardiovasc Diagn ; 32(3): 249-53, 1994 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7525075

RESUMEN

Respiratory failure is one of the most uncommon and serious adverse drug reactions. Low-molecular-weight-dextran (Dextran-40) is a useful adjunctive anti-platelet agent in the setting of coronary angioplasty and intracoronary stent placement. We report the occurrence of the adult respiratory distress syndrome following intravenous infusion of Dextran-40.


Asunto(s)
Dextranos/efectos adversos , Edema Pulmonar/inducido químicamente , Síndrome de Dificultad Respiratoria/inducido químicamente , Adulto , Angioplastia Coronaria con Balón/métodos , Enfermedad de la Arteria Coronaria/terapia , Dextranos/administración & dosificación , Femenino , Humanos , Infusiones Intravenosas
2.
Cathet Cardiovasc Diagn ; 31(3): 206-10, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8025938

RESUMEN

Selective infusion of urokinase into occluded coronary bypass vein grafts is effective in restoring patency. We report the occurrence of intracerebral hemorrhage complicating an intra-graft urokinase infusion protocol. The patient had known cerebral vascular structural pathology without recent clinical complications. Caution with the use of thrombolysis in this setting is suggested.


Asunto(s)
Hemorragia Cerebral/inducido químicamente , Puente de Arteria Coronaria , Oclusión de Injerto Vascular/tratamiento farmacológico , Terapia Trombolítica/efectos adversos , Activador de Plasminógeno de Tipo Uroquinasa/efectos adversos , Contraindicaciones , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Vena Safena/trasplante , Factores de Tiempo , Activador de Plasminógeno de Tipo Uroquinasa/administración & dosificación , Activador de Plasminógeno de Tipo Uroquinasa/uso terapéutico
3.
Cathet Cardiovasc Diagn ; 30(4): 348-54, 1993 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8287467

RESUMEN

Using agents administered systemically, attempts to control the restenotic myoproliferative response associated with angioplasty have been unsuccessful. The porous balloon has the advantage of achieving high local concentrations by directly infusing agents into the arterial wall. The purpose of this study is to identify any acute and chronic morphological changes in swine coronary arteries infused with normal saline through the porous balloon at different driving pressures. In order to establish the safety of local arterial wall infusion through the porous balloon, swine underwent porous balloon infusion of 3, 6, or 10 ml of saline at 5 atmospheres, or infusion of 3 ml of normal saline delivered at either 2, 5, or 10 atmospheres of pressure into the normal left anterior descending and left circumflex arteries. To assess the histopathologic alterations induced by the porous balloon, sized 1.1 to 1 with respect to the artery, animals were sacrificed either immediately after porous balloon infusion or 14 ays later. Acute vessels were evaluated for the presence of medial injury, disruption and/or dissection, whereas chronic vessels underwent morphometric analysis measuring the residual luminal area (Lumen area/Intimal area+Lumen area) and the maximal intimal thickness. Adequate adventitial penetration was confirmed by infusing as little as 2-3 ml of methylene blue at 2 atmospheres of pressure. Infusion of 3 ml of normal saline at 2 atmospheres resulted in minor focal medial edema and disorganization, detected both acutely and 14 days after porous balloon infusion. At delivery pressures of 5 or 10 atmospheres, proportionally more acute injury was noted and measurable neointimal lesions were observed 2 weeks after infusion.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Angioplastia Coronaria con Balón/instrumentación , Vasos Coronarios/patología , Angioplastia Coronaria con Balón/métodos , Animales , Angiografía Coronaria , Femenino , Porosidad , Cloruro de Sodio/administración & dosificación , Porcinos
4.
Angiology ; 44(11): 897-901, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8239061

RESUMEN

Hydroxylamine is a natural product of cellular metabolism that possesses vasodilating properties similar to those of endothelium-derived relaxing factor (EDRF). In the rodent pulmonary circulation preconstricted with the endoperoxide analog U-46619, hydroxylamine relaxed the vasculature in a concentration-dependent manner. Blockade of the hydroxylamine vasodilator response by methylene blue indicated that the mechanism of vasorelaxation is similar to that of EDRF. In this preparation, hydroxylamine is a more potent vasodilator than nitroglycerin.


Asunto(s)
Hidroxilaminas/farmacología , Circulación Pulmonar/efectos de los fármacos , Vasodilatadores/farmacología , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico , Animales , Presión Sanguínea/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Hidroxilamina , Técnicas In Vitro , Masculino , Nitroglicerina/farmacología , Endoperóxidos de Prostaglandinas Sintéticos/farmacología , Arteria Pulmonar/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Vasoconstrictores/farmacología
5.
Circulation ; 88(2): 628-37, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8339427

RESUMEN

BACKGROUND: Restenosis after percutaneous transluminal coronary angioplasty is the major limitation of the long-term success of this procedure. The process of restenosis is similar to an accelerated form of atherosclerosis. Thus, therapeutic interventions that limit the progression and initiation of atherosclerosis may be beneficial in the treatment of restenosis. One such intervention is the antioxidant drug probucol, which has demonstrated benefit in animal models of atherosclerosis. METHODS AND RESULTS: Twenty-six female domestic swine were divided into three study groups (control, n = 9; low-dose probucol, n = 9; high-dose probucol, n = 8) before oversized balloon injury of the left anterior descending and left circumflex coronary arteries. Probucol (1 g/d, low-dose group; 2 g/d, high-dose group) was administered 2 days before balloon injury and was continued until the swine were killed 2 weeks after balloon injury. Morphometric analysis of the injured arteries included the intimal area (square millimeters), maximal intimal thickness (millimeters), and residual lumen (ratio of luminal to intimal plus luminal area). Treatment with high-dose probucol significantly reduced neointimal formation compared with control animals (decreases of 36% in intimal area, P = .007; 20% in maximal intimal thickness, P = NS; and an increase of 15% in residual lumen, P = .02). CONCLUSIONS: The major finding of this study is that the antioxidant drug probucol reduces neointimal formation after oversized balloon injury in a swine model of restenosis. This suggests that active oxygen species may play a role in restenosis.


Asunto(s)
Antioxidantes/uso terapéutico , Cateterismo/efectos adversos , Enfermedad Coronaria/prevención & control , Enfermedad Coronaria/terapia , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/patología , Probucol/farmacología , Animales , Enfermedad Coronaria/patología , Femenino , Recurrencia , Porcinos
6.
J Am Coll Cardiol ; 20(2): 467-74, 1992 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1634687

RESUMEN

OBJECTIVES: This study was designed to compare the proliferative response in coronary arteries after tantalum stent placement or balloon injury in a normolipemic swine model of restenosis. BACKGROUND: Restenosis remains a significant complication of percutaneous transluminal coronary angioplasty. Efforts to study restenosis have been hampered by the lack of a suitable animal model. METHODS: In an attempt to create lesions resembling those of human restenosis, normolipemic swine underwent injury of either the left anterior descending or the left circumflex coronary artery with either balloon inflation or deployment of a tantalum stent. At 4 weeks, they were killed and the injured vessels processed for histopathologic analysis. Intimal area, lumen area and maximal intimal thickness were measured. The degree of stenosis was expressed as residual lumen area (lumen area/intimal area ratio). RESULTS: Vessels injured by either method demonstrated significant intimal smooth muscle proliferation leading to reduction in lumen area. In the 18 stented vessels residual lumen area measured 0.64 +/- 0.18 and maximal intimal thickness measured 0.6 +/- 0.3 mm; in the 15 balloon-injured vessels these values were 0.75 +/- 0.18 and 0.4 +/- 0.3 mm, respectively (p less than 0.05). In addition, most stented vessels had reactive inflammatory infiltrates surrounding the stent wires composed of lymphocytes, histiocytes and many eosinophils. CONCLUSIONS: These data indicate that coronary artery injury in swine with either balloon inflation or stenting leads to intimal smooth muscle cell proliferation similar to that seen in human restenosis. The degree of intimal proliferation appears to be greater after stenting than after balloon injury. Intracoronary stenting in swine is associated with a marked inflammatory reaction around the stent wires. These models may be helpful in planning systemic and local antirestenosis strategies.


Asunto(s)
Angioplastia Coronaria con Balón/efectos adversos , Vasos Coronarios/lesiones , Músculo Liso Vascular/lesiones , Stents , Animales , Enfermedad Coronaria/patología , Enfermedad Coronaria/terapia , Vasos Coronarios/patología , Hiperplasia , Músculo Liso Vascular/patología , Recurrencia , Porcinos
8.
Angiology ; 43(2): 163-8, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1536478

RESUMEN

The pulmonary vasoconstrictor responses to U-46619 and PGF2a are calcium dependent. The purpose of this investigation was to determine to what extent extracellular and intracellular calcium pools are utilized during the dose-dependent pulmonary vasopressor responses induced by multiple doses of U-46619 and PGF2a. Increasing doses of these agonists were administered to isolated rat lungs perfused with Krebs-Ringer bicarbonate (KRB) or KRB not containing CaCL2. The data indicate that U-46619 uses predominantly extracellular calcium at low doses (0.1 microgram) and depends solely on intracellular calcium at the highest dose (0.4 microgram). In contrast PGF2a appears to use depletable intracellular calcium stores to achieve contraction.


Asunto(s)
Calcio/fisiología , Dinoprost/farmacología , Endoperóxidos de Prostaglandinas Sintéticos/farmacología , Arteria Pulmonar/efectos de los fármacos , Vasoconstrictores/farmacología , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico , Animales , Relación Dosis-Respuesta a Droga , Técnicas In Vitro , Masculino , Perfusión/métodos , Arteria Pulmonar/fisiología , Ratas , Ratas Endogámicas , Vasoconstricción/efectos de los fármacos , Vasoconstricción/fisiología
9.
Clin Cardiol ; 14(10): 791-801, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1954687

RESUMEN

Restenosis is the most important problem limiting the success of coronary angioplasty. Clinically, restenosis is seen in approximately one-third of patients undergoing percutaneous transluminal coronary angioplasty. Several clinical and angiographic risk factors have been identified which may contribute to the development of restenosis. Histopathologic studies indicate that restenosis is characterized by intimal proliferation of smooth muscle cells in a loose connective tissue matrix. These intimal lesions are associated predominantly with the nonatheromatous portion of the vessel wall. Thinning of the media of the plaque-free wall and marked fragmentation of the internal elastic lamina are also seen. Traumatic injury of the vessel wall during angioplasty probably triggers a series of cellular and subcellular events which may ultimately lead to myointimal proliferation and restenosis. Although the exact mechanism by which this occurs is unknown, several factors may enhance smooth muscle cell growth and therefore may play a role in the development of restenosis. These include platelet deposition, mechanical stretching of the media, inflammation of the vessel wall, the activity of growth factors, and alterations in vessel geometry. These possible mechanisms of restenosis suggest several potential ways to limit the proliferative response to vascular injury. Anticoagulants and platelet antagonists, direct inhibitors of smooth muscle proliferation, anti-inflammatory agents, growth factor inhibitors, and new devices which improve final vessel geometry are currently being tested as methods to curb restenosis. Unfortunately, no treatment has yet been shown to reduce significantly the rate of restenosis following angioplasty. The problem of restenosis will most likely be solved by better understanding of the basic molecular and biologic phenomena involved in vascular injury and repair.


Asunto(s)
Angioplastia Coronaria con Balón/efectos adversos , Enfermedad Coronaria , Animales , Angiografía Coronaria , Enfermedad Coronaria/diagnóstico por imagen , Enfermedad Coronaria/epidemiología , Enfermedad Coronaria/terapia , Modelos Animales de Enfermedad , Humanos , Incidencia , Inhibidores de Agregación Plaquetaria/farmacología , Inhibidores de Agregación Plaquetaria/uso terapéutico , Ratas , Recurrencia , Factores de Riesgo , Trapidil/farmacología , Trapidil/uso terapéutico
10.
J Am Coll Cardiol ; 15(6): 1385-93, 1990 May.
Artículo en Inglés | MEDLINE | ID: mdl-2329241

RESUMEN

Because myocardial reperfusion injury may be caused by various blood constituents, a transient period of blood-free reperfusion was evaluated in closed chest dogs subjected to a 90 min angioplasty balloon occlusion of the left anterior descending coronary artery. In the treated group (n = 13), the balloon remained inflated for an additional 15 min while the infarct vessel was perfused with an acellular oxygenated perfluorochemical emulsion (Fluosol). The balloon was then deflated, permitting blood reperfusion. In the control group (n = 13), the balloon was deflated after 90 min of coronary occlusion. One week after infarction, the area at risk was defined in vivo by monastral blue dye staining, and the area of myocardial necrosis was assessed using triphenyltetrazolium chloride staining with histologic confirmation. Major determinants of infarct size, including rate-pressure product, area at risk and severity of myocardial ischemia (assessed by the extent of ST segment elevation during coronary occlusion), were not significantly different in the two groups. Treated dogs demonstrated a 47% reduction in infarct size expressed as a percent of the area at risk compared with control dogs (27.0 +/- 4.4% versus 50.8 +/- 4.4%, p less than 0.01). Treated dogs also demonstrated a superior global left ventricular ejection fraction (57.5 +/- 2.5% versus 51.0 +/- 2.2%, p less than 0.05) and anterolateral (regional) ejection fraction (32.6 +/- 3.6% versus 19.8 +/- 3.9%, p less than 0.05) compared with values in control dogs assessed by contrast ventriculography after 1 week of reperfusion. It is concluded that a transient period of blood-free reperfusion with an oxygenated perfluorochemical reduces reperfusion injury in a canine model of myocardial infarction.


Asunto(s)
Sustitutos Sanguíneos/administración & dosificación , Fluorocarburos/administración & dosificación , Infarto del Miocardio/terapia , Daño por Reperfusión Miocárdica/prevención & control , Reperfusión Miocárdica/métodos , Animales , Perros , Electrocardiografía , Masculino , Infarto del Miocardio/patología , Infarto del Miocardio/fisiopatología , Miocardio/patología , Necrosis/patología , Volumen Sistólico
11.
Am J Physiol ; 257(6 Pt 2): H2001-5, 1989 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2603984

RESUMEN

The role of calcium and calmodulin during U 46619 and PGF2 alpha-induced pulmonary vasoconstriction was studied in isolated rat lungs perfused with Krebs-Ringer bicarbonate (KRB) or calcium-free KRB. In lungs perfused with KRB, bolus injections of U 46619 (0.2 microgram) and PGF2 alpha (40.0 micrograms) resulted in a 48.0 +/- 4.0 and 23.9 +/- 2.5% increase in mean pulmonary artery pressure, respectively. During lung perfusion with KRB without calcium, the U 46619 response decreased to 31.1 +/- 7.5% whereas the PGF2 alpha response increased to 34.6 +/- 4.1%. Repeated challenges with PGF2 alpha in the KRB without calcium resulted in reduction of the response to 11.8 +/- 1.2%; the U 46619 response was unaltered. The intracellular calcium blocker, 8-(N,N-diethylamino)-octyl-3,4,5, trimethoxybenzoate HCL (TMB-8) significantly attenuated the pressor response to U 46619 at low doses and PGF2 alpha at high doses. The calmodulin inhibitor trifluoperazine (TFP 100 microM) attenuated the vasoconstrictor response to U 46619 by 54%, whereas the PGF2 alpha was unchanged. However, in the calcium-free KRB, TFP attenuated the pressor response to both U 46619 and PGF2 alpha. The U 46619 pressor response depends on intracellular and extracellular calcium to achieve calmodulin-dependent vasoconstriction. PGF2 alpha requires extracellular calcium to replenish depletable intracellular calcium pools and is independent of calmodulin activation.


Asunto(s)
Calcio/fisiología , Dinoprost/farmacología , Endoperóxidos de Prostaglandinas Sintéticos/farmacología , Circulación Pulmonar/efectos de los fármacos , Vasoconstricción/efectos de los fármacos , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico , Animales , Presión Sanguínea/efectos de los fármacos , Bloqueadores de los Canales de Calcio/farmacología , Calmodulina/fisiología , Ácido Gálico/análogos & derivados , Ácido Gálico/farmacología , Técnicas In Vitro , Pulmón/irrigación sanguínea , Masculino , Ratas , Ratas Endogámicas , Trifluoperazina/farmacología
12.
Angiology ; 38(1 Pt 1): 51-5, 1987 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-3468816

RESUMEN

In this study, TMB-8, an intracellular calcium antagonist, and verapamil, an extracellular calcium antagonist, were used simultaneously to elucidate the role of calcium in the pulmonary vasopressor response induced by PGF2 alpha and U46619. The pulmonary vasoconstrictor action of these two agonists was evaluated in the canine isolated lung lobe preparation. Lobar arterial pressure was constantly monitored and changes in arterial pressure were recorded as a percentage from baseline. Control responses to PGF2 alpha (42.0 +/- 8.2%) and U46619 (47.2 +/- 7.0%) were obtained prior to the administration of TMB-8 and verapamil. After administration of TMB-8 and verapamil, the PGF2 alpha (7.4 +/- 3.1%) and U46619 (28.8 +/- 6.2%) responses were significantly attenuated. We conclude that the PGF2 alpha pressor response is dependent on a TMB-8-sensitive intracellular calcium pool and a verapamil-sensitive slow-channel calcium influx. In contrast, the degree of attenuation of the U46619 response was similar to the vasopressor response in the presence of verapamil alone, as described previously. This indicates a direct dependence on extracellular calcium. An additional source of calcium insensitive to verapamil and TMB-8 may also be activated and contribute to the pulmonary vasoconstrictor action. These results suggest that each agonist possesses a mechanism of action distinctly different from the other.


Asunto(s)
Bloqueadores de los Canales de Calcio/farmacología , Ácido Gálico/análogos & derivados , Pulmón/efectos de los fármacos , Endoperóxidos de Prostaglandinas Sintéticos/farmacología , Prostaglandinas F/farmacología , Vasoconstricción/efectos de los fármacos , Verapamilo/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Calcio/metabolismo , Dinoprost , Perros , Femenino , Ácido Gálico/farmacología , Pulmón/irrigación sanguínea , Pulmón/fisiología , Masculino
13.
Br J Pharmacol ; 77(1): 55-8, 1982 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6957253

RESUMEN

1 TMB-8 (8-(N,N-diethylamino)octyl-3,4,5 trimethoxybenzoate HCl), an intracellular calcium antagonist, had no direct action on the pulmonary vasculature of the perfused canine lung lobe preparation. 2 The pulmonary pressor response to the thromboxane mimic, U46619, was not affected by TMB-8. 3 The vasopressor response to prostaglandin F2 alpha (PGF 2 alpha) was significantly attenuated but not completely blocked by TMB-8. 4 We conclude that the pulmonary pressor response to PGF 2 alpha is dependent on both intracellular and extracellular calcium pools for contraction and that U46619 facilitates either solely extracellular calcium influx or mobilizes an intracellular calcium pool not inhibited by TMB-8.


Asunto(s)
Ácido Gálico/análogos & derivados , Endoperóxidos de Prostaglandinas Sintéticos/farmacología , Prostaglandinas F/farmacología , Circulación Pulmonar/efectos de los fármacos , Vasoconstrictores , Animales , Calcio/metabolismo , Dinoprost , Perros , Femenino , Ácido Gálico/farmacología , Masculino , Norepinefrina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA